B55.9
Leishmaniasis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Leishmaniasis is a disease caused by microscopic parasites belonging to the Leishmania family. It is transmitted to humans through the bites of infected female sandflies. The disease can affect various parts of the body and presents in different forms, but when the specific type is not identified, it is classified under 'Leishmaniasis, unspecified' with the ICD-10 code B55.9. Recognizing the signs and understanding the causes are vital first steps in managing this disease effectively.
Causes & Symptoms
Clinical Causes: Living or traveling in areas where leishmaniasis is endemic Poor housing conditions that increase exposure to sandflies Deficiencies in the immune system, which make individuals more susceptible Certain occupational exposures, such as forestry or farming activities in endemic zones
Key Symptoms: Skin sores or ulcers that are usually painless but can become infected Swelling of the lymph nodes near affected areas Fever and chills in some cases Fatigue and weakness Weight loss and anemia in severe cases
Diagnostic & Treatment
Diagnosis Path: Microscopic examination of tissue samples from skin sores or lymph nodes to identify the parasite Culture of the parasite from tissue specimens Serological tests that detect antibodies against Leishmania Molecular methods such as PCR to detect parasite DNA Imaging studies in cases involving internal organs
Treatment Protocols: Antimonial drugs like sodium stibogluconate or meglumine antimoniate Amphotericin B, especially in resistant cases Miltefosine, which can be used orally in some forms of leishmaniasis Localized therapies, such as cryotherapy or topical treatments for skin sores Supportive care and nutritional support for systemic cases
Clinical Advice & FAQs
Billing Guidance
Is B55.9 a billable ICD-10 code?
Yes, B55.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B55.9?
Clinical documentation must specify the nature of Leishmaniasis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference